BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30563886)

  • 1. Smoking and Urinary Cotinine Levels Are Predictors of Increased Risk for Gastric Intestinal Metaplasia.
    Kim K; Chang Y; Ahn J; Yang HJ; Jung JY; Kim S; Sohn CI; Ryu S
    Cancer Res; 2019 Feb; 79(3):676-684. PubMed ID: 30563886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking, urinary cotinine levels and incidence of visual impairment.
    Han SY; Chang Y; Shin H; Choi CY; Ryu S
    Sci Rep; 2021 Jan; 11(1):398. PubMed ID: 33432008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication.
    Morales TG; Sampliner RE; Camargo E; Marquis S; Garewal HS; Fennerty MB
    J Clin Gastroenterol; 2001; 32(5):400-4. PubMed ID: 11319310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of self-reported and cotinine-verified smoking status with incidence of metabolic syndrome in 47 379 Korean adults.
    Kim BJ; Kang JG; Han JM; Kim JH; Lee SJ; Seo DC; Lee SH; Kim BS; Kang JH
    J Diabetes; 2019 May; 11(5):402-409. PubMed ID: 30306721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported and cotinine-verified smoking and increased risk of incident hearing loss.
    Lee W; Chang Y; Shin H; Ryu S
    Sci Rep; 2021 Apr; 11(1):8103. PubMed ID: 33854107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of and factors associated with urinary cotinine-verified smoking in Korean adults: The 2008-2011 Korea National Health and Nutrition Examination Survey.
    Hong JW; Noh JH; Kim DJ
    PLoS One; 2018; 13(6):e0198814. PubMed ID: 29889856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.
    Jung HS; Chang Y; Kwon MJ; Sung E; Yun KE; Cho YK; Shin H; Ryu S
    Am J Gastroenterol; 2019 Mar; 114(3):453-463. PubMed ID: 30353055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
    de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
    Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
    Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accuracy of flexible spectral imaging colour enhancement for the diagnosis of gastric intestinal metaplasia: do we still need histology to select individuals at risk for adenocarcinoma?
    Kikuste I; Stirna D; Liepniece-Karele I; Leja M; Dinis-Ribeiro M
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):704-9. PubMed ID: 24901816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body Mass Index and Risk of Intestinal Metaplasia: A Cohort Study.
    Kim K; Chang Y; Ahn J; Yang HJ; Jung JY; Kim S; Sohn CI; Ryu S
    Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):789-797. PubMed ID: 30700447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia: A Long-term Cohort Study.
    Lee TY; Wang RC; Lee YC; Lin JT; Ho HJ; Hsieh MC; Wu CY
    J Clin Gastroenterol; 2016 Aug; 50(7):532-7. PubMed ID: 26444645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the gastric mucosa in patients with intestinal metaplasia.
    Genta RM; Sonnenberg A
    Am J Surg Pathol; 2015 May; 39(5):700-4. PubMed ID: 25602799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia.
    Duan X; Lian H; Li J; Wu B; Wang W; Wu T; Wang C; Dou Y; Zhou Z; Wang B; Xue L; Wang G
    Diagn Pathol; 2019 Jun; 14(1):61. PubMed ID: 31221180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic diagnosis of gastric intestinal metaplasia: a prospective multicenter study.
    Fukuta N; Ida K; Kato T; Uedo N; Ando T; Watanabe H; Shimbo T;
    Dig Endosc; 2013 Sep; 25(5):526-34. PubMed ID: 23363394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of goblet cells upon endocytoscopy indicates the presence of gastric intestinal metaplasia.
    Chiu PW; Ng EK; To KF; Teoh AY; Lam CC; Chan FK; Sung JJ; Lau JY
    Dig Endosc; 2014 Jan; 26(1):52-6. PubMed ID: 23551261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration.
    Sakitani K; Hirata Y; Watabe H; Yamada A; Sugimoto T; Yamaji Y; Yoshida H; Maeda S; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1570-5. PubMed ID: 21575058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of cotinine-verified and self-reported smoking status with metabolic syndrome in 116,094 Korean adults.
    Kim BJ; Han JM; Kang JG; Rhee EJ; Kim BS; Kang JH
    J Clin Lipidol; 2017; 11(3):638-645.e2. PubMed ID: 28431854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal metaplasia of the gastric mucosa in autopsies of Chilean adults.
    Duarte I; Fonk ML; Llanos O; Guzmán S
    Pathol Res Pract; 1984 Jul; 178(6):538-42. PubMed ID: 6483680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal metaplasia of the gastric cardia: a study from Turkey.
    Dinçer D; Besisik F; Sahin E; Demir K; Tuncer I; Cevikbas U; Mungan Z; Kaymakoglu S; Boztas G; Ozdil S; Cakaloglu Y; Okten A
    Hepatogastroenterology; 2002; 49(46):1153-6. PubMed ID: 12143225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.